Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2901)
All Articles published online
|
Jul 28, 2008 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ye P, Weng ZH, Zhang SL, Zhang JA, Zhao L, Dong JH, Jie SH, Pang R, Wei RH. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection. World J Gastroenterol 2008; 14(28): 4551-4557 [PMID: 18680238 DOI: 10.3748/wjg.14.4551] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i28/4551.htm |
| Number | Citing Articles |
| 1 |
Pil Soo Sung, Dong Jun Park, Jung-Hee Kim, Ji Won Han, Eun Byul Lee, Gil Won Lee, Hee Chul Nam, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Eui-Cheol Shin, Su-Hyung Park, Seung Kew Yoon. Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01319
|
| 2 |
Jose Ramón Vidal-Castiñeira, Antonio López-Vázquez, Rebeca Alonso-Arias, Marco Antonio Moro-García, Pablo Martinez-Camblor, Santiago Melón, Jesús Prieto, Rosario López-Rodriguez, Paloma Sanz-Cameno, Luis Rodrigo, Rosa Pérez-López, Ramón Pérez-Álvarez, Carlos López-Larrea. A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping. Journal of Hepatology 2012; 56(6): 1230 doi: 10.1016/j.jhep.2012.01.011
|
| 3 |
Guoyu Zhang, Na Li, Zhu Li, Qianqian Zhu, Fang Li, Cuiling Yang, Qunying Han, Yi Lv, Zhihua Zhou, Zhengwen Liu. microRNA-4717 differentially interacts with its polymorphic target in the PD1 3′ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases. Oncotarget 2015; 6(22): 18933 doi: 10.18632/oncotarget.3662
|
| 4 |
Hui‐Han Hu, Wen‐Juei Jeng, Mei‐Hung Pan, Wun‐Sheng Luo, Chia‐Ling Chang, Yen‐Tsung Huang, Chien‐Yu Su, Chen‐Tse Chiang, Chin‐Lan Jen, Yu‐Chuan Chien, Shen‐Nan Lu, Li‐Yu Wang, Li‐Rung Huang, Mei‐Hsuan Lee, Jessica Liu, Mindie H. Nguyen, Chien‐Jen Chen, Hwai‐I Yang. Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2022; 55(5): 558 doi: 10.1111/apt.16752
|
| 5 |
Ludmila V. Sakhno, Marina A. Tikhonova, Tamara V. Tyrinova, Olga Yu. Leplina, Ekaterina Ya. Shevela, Sergey D. Nikonov, Oleg A. Zhdanov, Alexander A. Ostanin, Elena R. Chernykh. Cytotoxic Activity of Dendritic Cells as a Possible Mechanism of Negative Regulation of T Lymphocytes in Pulmonary Tuberculosis. Clinical and Developmental Immunology 2012; 2012: 1 doi: 10.1155/2012/628635
|
| 6 |
Y. Ülger, S. Bayram, M. Ü. Sandıkçı, E. Akgöllü, A. Bekar. Relationship between programmed cell death‐1 polymorphisms and clearance of hepatitis B virus. International Journal of Immunogenetics 2015; 42(3): 133 doi: 10.1111/iji.12187
|
| 7 |
Esmaeil Allahmoradi, Ramtin Mohammadi, Peyman Kheirandish Zarandi, Seyed Moayed Alavian, Mohammad Heiat. The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review. Expert Review of Clinical Immunology 2023; 19(6): 671 doi: 10.1080/1744666X.2023.2198209
|
| 8 |
Jil M. Jubel, Zachary R. Barbati, Christof Burger, Dieter C. Wirtz, Frank A. Schildberg. The Role of PD-1 in Acute and Chronic Infection. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00487
|
| 9 |
Juan Ramón Larrubia, Selma Benito-Martínez, Joaquín Miquel, Miryam Calvino, Eduardo Sanz-de-Villalobos, Trinidad Parra-Cid. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C. World Journal of Gastroenterology 2009; 15(41): 5129-5140 doi: 10.3748/wjg.15.5129
|
| 10 |
Junyan Feng, Lu Lu, Cong Hua, Ling Qin, Pingwei Zhao, Juan Wang, Ye Wang, Wanyu Li, Xiaodong Shi, Yanfang Jiang, Clive M. Gray. High Frequency of CD4+CXCR5+ TFH Cells in Patients with Immune-Active Chronic Hepatitis B. PLoS ONE 2011; 6(7): e21698 doi: 10.1371/journal.pone.0021698
|
| 11 |
F.‐Q. Hou, X.‐J. Wu, Y. Wang, J. Chen, Y.‐Z. Liu, Y.‐Y. Ren, G. Song, Y.‐P. Ding, M. Yu, G.‐Q. Wang. Rapid downregulation of programmed death‐1 and interferon‐γ‐inducible protein‐10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B. Journal of Viral Hepatitis 2013; 20(s1): 18 doi: 10.1111/jvh.12060
|
| 12 |
Hua-Yang ZHENG, Bi-Kui TANG, Pei-Wei WANG, Fang-Jian GAO, Xiao-Bo HU, Li GONG, Nai-Shuo ZHU. Identification and Characterization of The Promoter and Upstream Regulation Region of Mouse PD-1*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 2010; 37(5): 527 doi: 10.3724/SP.J.1206.2009.00664
|
| 13 |
Cheng-Zhong Li, Jing-Jing Hu, Jian-Ya Xue, Wei Yin, Ya-Yun Liu, Wen-Han Fan, Hao Xu, Xue-Song Liang. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B. World Journal of Gastroenterology 2014; 20(28): 9486-9496 doi: 10.3748/wjg.v20.i28.9486
|
| 14 |
Ping Xu, Yong-Jing Chen, Hui Chen, Xiao-Yan Zhu, Hua-Feng Song, Li-Juan Cao, Xue-Feng Wang. The Expression of Programmed Death-1 in Circulating CD4+and CD8+T Cells during Hepatitis B Virus Infection Progression and Its Correlation with Clinical Baseline Characteristics. Gut and Liver 2014; 8(2): 186 doi: 10.5009/gnl.2014.8.2.186
|
| 15 |
Guoyu Zhang, Na Li, Pingping Zhang, Fang Li, Cuiling Yang, Qianqian Zhu, Qunying Han, Yi Lv, Zhihua Zhou, Zhengwen Liu. PD-1 mRNA expression is associated with clinical and viral profile and PD1 3′-untranslated region polymorphism in patients with chronic HBV infection. Immunology Letters 2014; 162(1): 212 doi: 10.1016/j.imlet.2014.09.001
|
| 16 |
Daqiong Zhou, Lili Liu, Jiangyu Liu, Hong Li, Jing Zhang, Zhenhuan Cao. A Systematic Review of the Advances in the Study of T Lymphocyte Suppressor Receptors in HBV Infection: Potential Therapeutic Targets. Journal of Clinical Medicine 2024; 13(5): 1210 doi: 10.3390/jcm13051210
|
| 17 |
Junyan Feng, Xiaoli Hu, Hui Guo, Xiguang Sun, Juan Wang, Lijun Xu, Zhenyu Jiang, Bingchuan Xu, Junqi Niu, Yanfang Jiang. Patients with chronic hepatitis C express a high percentage of CD4+CXCR5+ T follicular helper cells. Journal of Gastroenterology 2012; 47(9): 1048 doi: 10.1007/s00535-012-0568-1
|
| 18 |
I-Tsu Chyuan, Hwei-Fang Tsai, Horng-Tay Tzeng, Chi-Chang Sung, Chien-Sheng Wu, Pei-Jer Chen, Ping-Ning Hsu. Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model. Cellular & Molecular Immunology 2015; 12(3): 317 doi: 10.1038/cmi.2015.01
|
| 19 |
Fen Huang, Bo Wang, Jiangzheng Zeng, Shenggang Sang, Junhua Lei, Yanda Lu. MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.7951
|